Join us for our next Insights Forum:

Save the date for our next Insights Forum:
Friday, June 16, 2023
10 - 11:30 a.m. Pacific
10 - 11:30 a.m. Pacific
Forum Topic: Will Artificial Intelligence (AI) revolutionize cancer treatment, diagnosis, and prevention?
Panelists:
• Regina Barzilay, PhD | MIT Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic)
• Clifford Hudis, MD, FACP, FASCO | American Society of Clinical Oncology
• Najat Khan, PhD | Janssen (Johnson & Johnson)
• Olga Troyanskaya, PhD | Princeton University & Flatiron Institute of the Simons Foundation
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
• Regina Barzilay, PhD | MIT Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic)
• Clifford Hudis, MD, FACP, FASCO | American Society of Clinical Oncology
• Najat Khan, PhD | Janssen (Johnson & Johnson)
• Olga Troyanskaya, PhD | Princeton University & Flatiron Institute of the Simons Foundation
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
Panelists:
• Regina Barzilay, PhD | MIT Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic)
• Clifford Hudis, MD, FACP, FASCO | American Society of Clinical Oncology
• Najat Khan, PhD | Janssen (Johnson & Johnson)
• Olga Troyanskaya, PhD | Princeton University & Flatiron Institute of the Simons Foundation
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
• Regina Barzilay, PhD | MIT Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic)
• Clifford Hudis, MD, FACP, FASCO | American Society of Clinical Oncology
• Najat Khan, PhD | Janssen (Johnson & Johnson)
• Olga Troyanskaya, PhD | Princeton University & Flatiron Institute of the Simons Foundation
Moderated by:
• David Agus, MD | Ellison Institute
• Anna Barker, PhD, FAACR | Ellison Institute
Dating from the 1950’s, artificial intelligence (AI) is certainly not a new concept. In fact, AI evolved to the present day over several decades with periods of both progress and paralysis. Over these decades, AI machines began to store and iterate human intelligence through neural networks and achieved deep learning to replace myriad human capabilities. OpenAI was founded in 2015 and released Chat Generative Pre-Trained Transformer (ChatGPT) in 2022. AI now clearly has everyone’s attention, including some well-founded fears for its future evolution.
During the decades when the sophistication of the algorithms and neural network-based AI of today were evolving, a similar, and synergistic movement, was occurring in oncology. Advanced technologies were fueling an unprecedented “big data tsunami” with associated advances in analytics. The big data revolution in cancer has informed, and been informed by, artificial intelligence that is now driving new, non-traditional approaches to diagnosing, treating, and preventing cancer. Although AI may well prove to be transformative for Cancer, should we worry about the concept that AI could someday advance to a point where machine intelligence surpasses human intelligence (AI evolves to become self-aware) – or is this threat the stuff of science fiction?
Join us for this Insights Forum as we explore the state of numerous efforts to apply AI to cancer, what to expect in terms of potential advances (or not) during the next decade and beyond, and what we should fear, if anything?
During the decades when the sophistication of the algorithms and neural network-based AI of today were evolving, a similar, and synergistic movement, was occurring in oncology. Advanced technologies were fueling an unprecedented “big data tsunami” with associated advances in analytics. The big data revolution in cancer has informed, and been informed by, artificial intelligence that is now driving new, non-traditional approaches to diagnosing, treating, and preventing cancer. Although AI may well prove to be transformative for Cancer, should we worry about the concept that AI could someday advance to a point where machine intelligence surpasses human intelligence (AI evolves to become self-aware) – or is this threat the stuff of science fiction?
Join us for this Insights Forum as we explore the state of numerous efforts to apply AI to cancer, what to expect in terms of potential advances (or not) during the next decade and beyond, and what we should fear, if anything?
Dating from the 1950’s, artificial intelligence (AI) is certainly not a new concept. In fact, AI evolved to the present day over several decades with periods of both progress and paralysis. Over these decades, AI machines began to store and iterate human intelligence through neural networks and achieved deep learning to replace myriad human capabilities. OpenAI was founded in 2015 and released Chat Generative Pre-Trained Transformer (ChatGPT) in 2022. AI now clearly has everyone’s attention, including some well-founded fears for its future evolution.
During the decades when the sophistication of the algorithms and neural network-based AI of today were evolving, a similar, and synergistic movement, was occurring in oncology. Advanced technologies were fueling an unprecedented “big data tsunami” with associated advances in analytics. The big data revolution in cancer has informed, and been informed by, artificial intelligence that is now driving new, non-traditional approaches to diagnosing, treating, and preventing cancer. Although AI may well prove to be transformative for Cancer, should we worry about the concept that AI could someday advance to a point where machine intelligence surpasses human intelligence (AI evolves to become self-aware) – or is this threat the stuff of science fiction?
Join us for this Insights Forum as we explore the state of numerous efforts to apply AI to cancer, what to expect in terms of potential advances (or not) during the next decade and beyond, and what we should fear, if anything?
During the decades when the sophistication of the algorithms and neural network-based AI of today were evolving, a similar, and synergistic movement, was occurring in oncology. Advanced technologies were fueling an unprecedented “big data tsunami” with associated advances in analytics. The big data revolution in cancer has informed, and been informed by, artificial intelligence that is now driving new, non-traditional approaches to diagnosing, treating, and preventing cancer. Although AI may well prove to be transformative for Cancer, should we worry about the concept that AI could someday advance to a point where machine intelligence surpasses human intelligence (AI evolves to become self-aware) – or is this threat the stuff of science fiction?
Join us for this Insights Forum as we explore the state of numerous efforts to apply AI to cancer, what to expect in terms of potential advances (or not) during the next decade and beyond, and what we should fear, if anything?
REGISTER NOW
Past Insights Forum Recordings
PROGRESS AGAINST THE MOST LETHAL CANCERS
February 2023
______
Why are improvements in survival not occurring in some of the most lethal cancers? Are advances in the molecular sciences and approaches, such as immunotherapy, that are driving precision medicine impacting death rates in metastatic cancers?
February 2023
______
Why are improvements in survival not occurring in some of the most lethal cancers? Are advances in the molecular sciences and approaches, such as immunotherapy, that are driving precision medicine impacting death rates in metastatic cancers?
IMMUNOTHERAPHY
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
WHAT ARE WE MISSING IN OUR 50-YEAR QUEST TO FUNDAMENTALLY UNDERSTAND & CONTROL CANCER?
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
PRECISION ONCOLOGY: SEPARATING HOPE FROM HYPE
May 2022
______
Where, how, and why is precision oncology working predictably and well?
Where and why is precision oncology not working well - or at all?
What is needed for all cancer patients to have access to efficacious precision
oncology in the future?
May 2022
______
Where, how, and why is precision oncology working predictably and well?
Where and why is precision oncology not working well - or at all?
What is needed for all cancer patients to have access to efficacious precision
oncology in the future?
EARLY CANCER DETECTION & PREVENTION:
THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
INFORMATION THEORY
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
THE PHYSICS OF CANCER
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
DECONVOLUTING CANCER COMPLEXITY
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
REVOLUTIONIZING CANCER TREATMENT THROUGH EVOLUTIONARY THEORY
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
PRECISION MEDICINE FOR COVID-19
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
PROGRESS AGAINST THE MOST LETHAL CANCERS
February 2023
______
Why are improvements in survival not occurring in some of the most lethal cancers? Are advances in the molecular sciences and approaches, such as immunotherapy, that are driving precision medicine impacting death rates in metastatic cancers?
February 2023
______
Why are improvements in survival not occurring in some of the most lethal cancers? Are advances in the molecular sciences and approaches, such as immunotherapy, that are driving precision medicine impacting death rates in metastatic cancers?
IMMUNOTHERAPY
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
December 2022
______
If cancer immunotherapy is the answer to improving treatment or even curing or preventing most cancers, what are the research imperatives at this point? Are we doing enough to address these imperatives? If not, why not, and how can that be remedied?
WHAT ARE WE MISSING IN OUR 50-YEAR QUEST TO FUNDAMENTALLY UNDERSTAND & CONTROL CANCER?
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
September 2022
______
Cancer is complex. It is a complex adaptive system, but is it irreducibly complex? If not, what are we missing that could enable progress? Our panel of experts explored this question and provided their insights.
PRECISION ONCOLOGY: SEPARATING HOPE FROM HYPE
May 2022
______
Where, how, and why is precision oncology working predictably and well? Where and why is precision oncology not working well - or at all? What is needed for all cancer patients to have access to efficacious precision oncology in the future?
May 2022
______
Where, how, and why is precision oncology working predictably and well? Where and why is precision oncology not working well - or at all? What is needed for all cancer patients to have access to efficacious precision oncology in the future?
EARLY CANCER DETECTION & PREVENTION: THE NEW FRONTIER
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
February 2022
______
Are we on the cusp of a revolution in cancer? Is early detection of cancer the new frontier in cancer progression--or not? If so, what will be required (e.g., intervention strategies/technologies) to achieve needed changes in all sectors? If not, could very early detection of pre-cancer "signals" create unprecedented challenges?
INFORMATION THEORY
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
October 2021
______
If cancer is a dynamic information-driven complex adaptive system, what steps must be taken to shift from studying its “parts” vs. decoding and decrypting the information we need to identify and understand the flow of information and the logic of the system?
THE PHYSICS OF CANCER
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
July 2021
______
In the context of the convergence of the physical sciences with cancer biology, is research in the physical sciences clinically relevant? What will it take to advance promising areas of the physical sciences to solve critical questions in cancer that could lead to clinical breakthroughs?
DECONVOLUTING CANCER COMPLEXITY
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
May 2021
______
We are awash in data from cancer patients, but if data are not information, what and where is dysregulated cancer information, how do we collect it and is it critical for the diagnosis and treatment of cancer?
REVOLUTIONIZING CANCER TREATMENT THROUGH EVOLUTIONARY THEORY
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
March 2021
______
How could applying specific principles of evolution / evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?
PRECISION MEDICINE FOR COVID-19
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?
January 2021
______
Can we use the precision cancer medicine model to inform and improve the diagnosis and prevention of COVID-19 infections and treatment of the disease(s) it causes?